Skip to main content
. 2018 Mar 21;33(1):17–32. doi: 10.3803/EnM.2018.33.1.17

Table 1. Incidence of Cardiovascular-Renal Complications in Hong Kong Chinese with Type 2 Diabetes and the Benefits of Team-Based Structured Care in High and Low Risk Patients Managed in Both Public and Private-Public Partnership Settings since 1995.

CUHK-PWH Hong Kong Diabetes Register [8]
1995–2007, 1 public hospital, 8,558 patients, median duration of diabetes 5 years
 Patients with complications after median follow-up 6.7 years, %
  CKD 32.5
  CVD 15.1
  Death 11.8 (cancer 23.7, circulatory disease 23.3, renal disease 13.4)
Territory-wide Hong Kong Diabetes Database [50]
2000–2012, primary and secondary care settings, subgroup with duration of diabetes >15 years
 Cohort year 2000–2003 2010–2012
 No. of patients 33,143 147,819
 Incidence (per 1,000 person-years [95% CI])
  ESRD 25.75 (22.35–29.67) 22.46 (20.86–24.17)
  Stroke 13.53 (11.06–16.56) 10.13 (9.04–11.34)
  AMI 8.68 (6.75–11.18) 5.76 (4.94–6.71)
  Death 29.03 (25.46–33.11) 26.55 (24.84–28.38)
Risk Assessment Management Program in public primary care setting [53]
2009–2011, territory-wide public primary care clinics in low risk patients
Public-RAMP Propensity-score matched control
 No. of patients 8,570 8,570
 Mean duration of diabetes, yr 8.67 8.54
 Patients with events after 5 years follow-up period, %
  CVD 12.33 23.97
  Stroke 5.19 8.48
  Death 7.96 21.35
Public vs. PPP-JADE Program [57]
2007–2015, PPP: university-affiliated diabetes centre, private doctors and JADE technology
Public PPP-JADE
 No. of patients 3,570 3,424
 Median duration of diabetes, yr 9 7.4
 Median follow-up, yr 3.2 5.1
 Incidence (per 1,000 person-years [95% CI])a
  CKD 86.6 (80.32–93.39) 39.96 (36.38–43.54)
  ESRD 15.6 (13.44–18.11) 7.06 (5.92–8.43)
  CHD 7.19 (5.71–9.06) 5.56 (4.5–6.87)
  Stroke 6.39 (5.03–8.13) 4.09 (3.22–5.19)
  Death 15.19 (13.09–17.62) 8.54 (7.28–10.03)

CUHK-PWH, The Chinese University of Hong Kong–Prince of Wales Hospital; CKD, chronic kidney disease; CVD, cardiovascular disease; CI, confidence interval; ESRD, end stage renal disease; AMI, acute myocardial infarction; RAMP, Risk Assessment and Management Program; PPP-JADE, Private Public Partnership–Joint Asia Diabetes Evaluation; CHD, coronary heart disease.

aConsistent benefits in favor of PPP in patients with different risk profiles.